Information Library
Results for: Cost control/reduction - High-quality studies
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Quintiles Appoints Global Head of Phase I Division
Press Release — August 31, 2011 – Quintiles announced that Oren Cohen, M.D., will serve as Senior Vice President and Global Head of its Phase I Clinical Research division, which includes world-class facilities in Overland Park, Kansas (U.S.), London (U.K.) and Hyderabad (India).
-
Population PK/PD - Modeling and Simulation Optimization Tools
Brochure — February 11, 2011
Population pharmacokinetic/ pharmacodynamic (PK/PD) modeling and simulation, available from Quintiles, is now endorsed by the FDA as often being instrumental in drug approval and labeling. -
QUINTILES EXTENDS DATA MANAGEMENT EXPERTISE, CAPABILITIES TO CHINA
Press Release — August 9, 2010 - Quintiles announced the expansion of its data management services into Shanghai, China, strengthening the company’s capability to serve customers in that country and the Asia-Pacific region.
-
Managing Pharmacovigilance as a Business
White Paper — July 28, 2010
The three steps required to develop a strategic approach to global capacity management. -
New FDA Guidance on Antidiabetic Therapies
White Paper — December 11, 2009
Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program. -
Phase One Services: Dr. Elizabeth Allen
Video — July 24, 2009
We provide accurate and correct Phase I and IIa data quickly. We can help you make smart, safe decisions earlier to avoid repeating costly studies later. -
Phase One Services: Dr. Philip T. Leese
Video — July 24, 2009
To deliver quality data on time, we ensure that all clinical conduct is consistent, efficient and accurate to your protocol. But to do this we also need to recruit the right volunteers. -
Phase One Services: Professor Timothy G.K. Mant
Video — July 24, 2009
It's absolutely crucial that your Phase I/IIa partner places ethics, safety and expert clinical conduct at the heart of all their activities. -
Early phase strategies
Hear from the Experts — June 15, 2009
Web cast about Early Phase Strategies. -
Jim Featherstone, Ph.D.
Hear from the Experts — March 25, 2009
Jim joined Quintiles Consulting from Wood Mackenzie, a leading business intelligence and strategy consulting services company based in the UK, where he was the Global Head of Consulting for the Pharmaceuticals and Biotechnology practice.